I have a job interview for a position as a Benefits Consultant for Aflac. I didn't know anything about this job so I did some research and I think I can do the job if I'm hired. I have no experience by they'll train you. I want to know more about this position I hope it's not too stressful but I am...
DNKN is trading in the range of $40.50 - $46.55 in the past 30 days. The stock has been showing support around the level of $42 and resistance in the $52 range. The stock is trading below the 50-Day Moving Average and below the 200-Day Moving Average.
The company is expected to have losses of $0.19 per share in 2015 and $0.05 per share in 2016. After seeing such a jump in reaction to the announcement, analysts could not help but weigh in on Dyax after the news broke. Again, some of the price target hikes are nothing short of huge. Oppenheimer maintained an Outperform rating and raised the price target to $26 from $14. RBC Capital Markets maintained its Outperform rating and raised the price target to $31 from $18.